Ikarian Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ikarian Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-261,365	Closed	-$10.4M	–	159
2024 Q1	$10.4M	Sell	261,365 -225,883	-46%	-$6.67M	1.14%	26
2023 Q4	$9.29M	Buy	+487,248	New	+$6.77M	0.87%	38
2021 Q3	–	Sell	-300,454	Closed	-$2.7M	–	261
2021 Q2	$2.7M	Sell	300,454 -4,285	-1%	-$46.6K	0.22%	108
2021 Q1	$3.23M	Buy	304,739 +300,000	+6,330%	+$3.74M	0.11%	165
2020 Q4	$60K	Hold	4,739	–	–	﹤0.01%	221
2020 Q3	$41K	Hold	4,739	–	–	﹤0.01%	170
2020 Q2	$46K	Buy	+4,739	New	+$20.5K	﹤0.01%	162
2020 Q1	–	Sell	-4,739	Closed	-$18K	–	184
2019 Q4	$18K	Buy	+4,739	New	+$14.8K	﹤0.01%	113

Ikarian Capital's ALPN Position: Q2 2024 in Review

Ikarian Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 261,365 shares — an estimated $10.4M sold.

Ikarian Capital first reported a position in ALPN in Q4 2019 and held it in 8 quarters. The position peaked at $10.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Ikarian Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Ikarian Capital sold 261,365 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.4M.
Ikarian Capital first reported a position in Alpine Immune Sciences Inc in Q4 2019 and held it in 8 quarters.
Ikarian Capital's Alpine Immune Sciences Inc position peaked at $10.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Ikarian Capital's 13F filing for Q2 2024, filed 14 Aug 2024.